Brian Appleby, MD
Geriatric Psychiatry · Cleveland, OHNPI 1558417030
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,900 of the $5,982 with a category attached, or 81.9%. 5 manufacturers reported payments, led by Merck at 54.3% of the total.
Across 9 payments — averaging $664.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
- Acadia Pharmaceuticals Inc$2K
- Lundbeck LLC$1K
- Eisai Inc.$29
- Lilly USA, LLC$16
Across 24 payments — averaging $14,087 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ionis Pharmaceuticals, Inc.$338K
What the payments were for
- Consulting fees$4,90082%
- Speaking & faculty fees$90015%
- Food & beverage$1823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $3,250 |
| Acadia Pharmaceuticals Inc | 1 | $1,650 |
| Lundbeck LLC | 2 | $1,038 |
| Eisai Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$1,650
- REXULTI$900
- ABILIFY ASIMTUFII$138
How this compares
Too few geriatric psychiatry providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 62 | $5,290 |
| Rivastigmine | 14 | $3,624 |
| Quetiapine Fumarate | 52 | $1,682 |
| Memantine Hcl ErMemantine Hcl | 11 | $1,267 |
| Duloxetine Hcl | 35 | $1,245 |
| Aripiprazole | 19 | $1,197 |
| Bupropion XlBupropion Hcl | 29 | $957 |
| Sertraline Hcl | 86 | $935 |
| Buspirone Hcl | 25 | $847 |
| Donepezil Hcl | 63 | $709 |
| Levetiracetam | 55 | $417 |
| Trazodone Hcl | 36 | $247 |
| Lamotrigine | 13 | $101 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $80 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Cleveland
- Kasia RothenbergCleveland$6K
- Philipp DinesCleveland$462
- Babu GuptaCincinnati$11K
- Alfredo RiveraCincinnati$2K
- Chander MohanShelby$2K
- Rebecca SchlachetEuclid$496
- Louis KleinRocky River$280
- Upma DhingraEuclid$277
- Robert SegravesBeachwood$251
- Ravinder MannCincinnati$202
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.